MISRA TUSHAR 4
4 · Mersana Therapeutics, Inc. · Filed Aug 18, 2023
Insider Transaction Report
Form 4
MISRA TUSHAR
Chief Manufacturing Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2023-08-16−6,250→ 12,500 total→ Common Stock (6,250 underlying) - Exercise/Conversion
Common Stock
2023-08-16+6,250→ 13,415 total - Sale
Common Stock
2023-08-17$1.18/sh−1,908$2,251→ 11,507 total
Footnotes (5)
- [F1]Represents shares of common stock received upon vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on August 16, 2021.
- [F2]Includes 1,235 shares of common stock acquired on June 15, 2023 by the Reporting Person through the Issuer's employee stock purchase plan.
- [F3]Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 10, 2023. The sale was effected through an automatic "sell to cover" transaction that did not represent a discretionary trade by the Reporting Person.
- [F4]Each RSU represents the contingent right to receive one share of common stock of the Issuer.
- [F5]The RSUs will vest in equal annual installments over the first four years after the vesting commencement date, August 16, 2021, subject to the Reporting Person's continued service to the Issuer on such vesting date.